Abstract No. 181: Improvement of VX2 tumor model by transfection with vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (bFGF)
Florentina Pascale, A. Laurent(Hôpital Lariboisière), Michel Wassef(Université Paris Cité), Isabelle Schwartz-Cornil(Institut National de la Recherche Agronomique), Valentin Verret(Fondation HEC), M. Bonneau(Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement), Laurent Bédouet, S. Ghegediban(Délégation Paris 7), Julien Namur(Centre National de la Recherche Scientifique)
Cited by 2
Related Papers
Vascular Anomalies Classification: Recommendations From the International Society for the Study of Vascular Anomalies
|PEDIATRICS|2015|1.4k
Infants with Kasabach-Merritt syndrome do not have “true” hemangiomas
|The Journal of Pediatrics|1997|499
Rapidly Involuting Congenital Hemangioma: Clinical and Histopathologic Features
|Pediatric and Developmental Pathology|2003|360
Noninvoluting Congenital Hemangioma: A Rare Cutaneous Vascular Anomaly
|Plastic & Reconstructive Surgery|2001|329
Residual lesions after Kasabach-Merritt phenomenon in 41 patients☆, ☆☆
|Journal of the American Academy of Dermatology|2000|265